In future studies, we would like to further characterize the tdEVs to confirm that they are of tumor origin by evaluating the expression of prostate-specific proteins such as PSMA on tdEVs, and performing downstream analyses such as RNA sequencing to confirm the presence of prostate cancer-specific RNAs. This evidence concerns the gene FOLH1 and prostate carcinoma.